Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection

The prognosis of intrahepatic cholangiocarcinoma (ICC) remains poor whereas predictive models for survival prediction in ICC patients following curative resection are limited. Herein, we established a novel inflammation-based score derived from preoperative albumin to gamma-glutamyltransferase ratio (AGR) and evaluated its prognostic significance in ICC patients underwent curative resection. Prognostic value of AGR was retrospectively studied in a cohort comprising 206 ICC patients following curative resection. The predictive performance of AGR was compared with other inflammation-based scores and serological tumor markers in terms of concordance index (C-index). Further, prognostic nomograms incorporating AGR into the tumor-node-metastasis (TNM) staging systems were established to achieve a better discriminatory ability. The optimal cut-off value of AGR was 0.6. Multivariate analysis showed that AGR was an independent predictor for overall survival (OS; P = 0.003) and recurrence-free survival (RFS; P = 0.046). The C-index of AGR was superior to other inflammation-based scores and serological tumor markers in OS and RFS prediction. The established nomograms showed improved predictive accuracy compared with the TNM staging systems alone. These results indicate that AGR is an independent prognostic indicator for ICC underwent curative resection. The incorporation of AGR into the existing TNM staging systems achieved improved predictive accuracy.

[1]  M. Smolkin,et al.  Prognostic value of albumin in patients with head and neck cancer , 2016, The Laryngoscope.

[2]  Lequn Li,et al.  Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma , 2016, The British journal of surgery.

[3]  Y. Huang,et al.  Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer , 2016, Medicine.

[4]  S. Qiu,et al.  A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection , 2016, Medicine.

[5]  G. Cooke,et al.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.

[6]  Z. Wang,et al.  Negative Impact of Preoperative Platelet-Lymphocyte Ratio on Outcome After Hepatic Resection for Intrahepatic Cholangiocarcinoma , 2015, Medicine.

[7]  K. Koike,et al.  The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.

[8]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Jia Fan,et al.  The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy , 2015, Tumor Biology.

[10]  V. Wong,et al.  Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma , 2015, Disease markers.

[11]  X. Salvatella,et al.  Human serum albumin, systemic inflammation, and cirrhosis. , 2014, Journal of hepatology.

[12]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[13]  T. Pawlik,et al.  A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. , 2014, JAMA surgery.

[14]  S. Ye,et al.  γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.

[15]  T. Joh,et al.  Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle , 2014, International journal of molecular sciences.

[16]  S. Qiu,et al.  Elevation of serum &ggr;-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study , 2013, European journal of gastroenterology & hepatology.

[17]  J. Everhart,et al.  Association of γ‐glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV) , 2013, Hepatology.

[18]  Kui Wang,et al.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Mira,et al.  Specific antioxidant properties of human serum albumin , 2013, Annals of Intensive Care.

[20]  I. Fentiman Gamma-glutamyl transferase: risk and prognosis of cancer , 2012, British Journal of Cancer.

[21]  B. North,et al.  A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) , 2012, British Journal of Cancer.

[22]  N. Concin,et al.  Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial , 2012, British Journal of Cancer.

[23]  N. Concin,et al.  Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer. , 2011, Gynecologic oncology.

[24]  F. Pruvot,et al.  AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma , 2011, Cancer.

[25]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[26]  Y. Maehara,et al.  p62+ Hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease. , 2010, American journal of clinical pathology.

[27]  O. Farges,et al.  Clinical presentation and management of intrahepatic cholangiocarcinoma. , 2010, Gastroenterologie clinique et biologique.

[28]  Zhao-You Tang,et al.  Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation , 2009, Journal of Gastroenterology.

[29]  I. Endo,et al.  Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.

[30]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  J. West,et al.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001 , 2006, British Journal of Cancer.

[32]  F. Stickel,et al.  Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress , 2006, Biological chemistry.

[33]  G. Kaysen,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.

[34]  D. Jacobs,et al.  Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? , 2004, Free radical biology & medicine.

[35]  Dean P. Jones,et al.  Extracellular thiols and thiol/disulfide redox in metabolism. , 2004, Annual review of nutrition.

[36]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[37]  S. Yamasaki Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. , 2003, Journal of hepato-biliary-pancreatic surgery.

[38]  M. Makuuchi,et al.  A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.

[39]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[40]  J. Hafkenscheid,et al.  Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. , 1987, The Journal of clinical investigation.

[41]  N. Meydan,et al.  Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[42]  Y. Maehara,et al.  p 62-positive Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated with Viral Hepatitis or Alcoholic Liver Disease Running title : Hyaline inclusions in cholangiocarcinoma , 2013 .

[43]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[44]  M. Choti,et al.  A Proposed Staging System for Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.